CA2167942A1 - Method of inhibiting kaposi's sarcoma - Google Patents
Method of inhibiting kaposi's sarcomaInfo
- Publication number
- CA2167942A1 CA2167942A1 CA002167942A CA2167942A CA2167942A1 CA 2167942 A1 CA2167942 A1 CA 2167942A1 CA 002167942 A CA002167942 A CA 002167942A CA 2167942 A CA2167942 A CA 2167942A CA 2167942 A1 CA2167942 A1 CA 2167942A1
- Authority
- CA
- Canada
- Prior art keywords
- apoe
- cells
- kaposi
- sarcoma
- apolipoprotein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Oscillators With Electromechanical Resonators (AREA)
- Amplifiers (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10590093A | 1993-08-12 | 1993-08-12 | |
US08/105,900 | 1993-08-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2167942A1 true CA2167942A1 (en) | 1995-02-23 |
Family
ID=22308419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002167942A Abandoned CA2167942A1 (en) | 1993-08-12 | 1994-08-12 | Method of inhibiting kaposi's sarcoma |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0715521A4 (de) |
AU (1) | AU7526494A (de) |
CA (1) | CA2167942A1 (de) |
IL (1) | IL110638A0 (de) |
WO (1) | WO1995005190A1 (de) |
ZA (1) | ZA946090B (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA935879B (en) * | 1992-08-12 | 1994-03-11 | Bio Technology General Corp | Method of inhibiting cell proliferation using apolipoprotein E. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5177189A (en) * | 1989-08-18 | 1993-01-05 | The Scripps Research Institute | Polypeptide analogs of Apolipoprotein E |
WO1993000443A1 (en) * | 1991-06-26 | 1993-01-07 | Bio-Technology General Corp. | Purification of recombinant apolipoprotein e from bacteria |
ZA935879B (en) * | 1992-08-12 | 1994-03-11 | Bio Technology General Corp | Method of inhibiting cell proliferation using apolipoprotein E. |
-
1994
- 1994-08-12 IL IL11063894A patent/IL110638A0/xx unknown
- 1994-08-12 CA CA002167942A patent/CA2167942A1/en not_active Abandoned
- 1994-08-12 ZA ZA946090A patent/ZA946090B/xx unknown
- 1994-08-12 AU AU75264/94A patent/AU7526494A/en not_active Abandoned
- 1994-08-12 EP EP94925276A patent/EP0715521A4/de not_active Withdrawn
- 1994-08-12 WO PCT/US1994/009192 patent/WO1995005190A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL110638A0 (en) | 1994-11-11 |
EP0715521A4 (de) | 1998-01-14 |
EP0715521A1 (de) | 1996-06-12 |
ZA946090B (en) | 1995-11-22 |
AU7526494A (en) | 1995-03-14 |
WO1995005190A1 (en) | 1995-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU617126B2 (en) | A polypeptide growth factor from milk | |
JP3710815B2 (ja) | Il−2発現に適したプラスミド | |
Woloski et al. | Identification and partial characterization of hepatocyte-stimulating factor from leukemia cell lines: comparison with interleukin 1. | |
US7718604B2 (en) | Use of IL-22 for the treatment of conditions of metabolic disorders | |
EP2552470B1 (de) | Peptide zur angiogeneseförderung und verwendung davon | |
HRP960213A2 (en) | RECOMBINANT OBESE (Ob) PROTEINS | |
US6191106B1 (en) | Muteins of epidermal growth factor exhibiting enhanced binding at low pH | |
EP0876152A1 (de) | Neue verabreichung von thrombopoietin | |
CN115089698A (zh) | 改善皮肤的活性肽与干细胞外泌体在药品或化妆品中的应用 | |
AU625807B2 (en) | Uses of recombinant colony stimulating factor-1 | |
AU1901501A (en) | Antimcrobial activity of the first cationic cluster of human lactoferrin | |
AU673543B2 (en) | Method of inhibiting cell proliferation using apolipoprotein E | |
US5616554A (en) | Immune-enhancing agent for therapeutic use in immunocompromised hosts | |
US5725850A (en) | Use of CSF-1 to treat tumor burden | |
CN101671390B (zh) | 人干扰素α衍生物及其聚乙二醇化修饰物的制备和用途 | |
CA2167942A1 (en) | Method of inhibiting kaposi's sarcoma | |
JPH04506818A (ja) | 造血細胞の成熟 | |
JPH02157231A (ja) | 細胞増殖抑制剤 | |
WO1996011700A1 (en) | Reduction of mammalian neoplasms with phospholipase a2 activatiing substances | |
EP0679659B1 (de) | Inhibitor peptid spezifisch für cathepsin-l | |
NZ506695A (en) | Utilization of cd137 in order to promote the profileration of peripheral monocytes | |
US5837229A (en) | Uses of recombinant colony stimulating factor-1 | |
JPH022391A (ja) | ヒトm―csf及びその製造法 | |
JP3580836B2 (ja) | 好中球減少症治療剤 | |
SI8212335A8 (sl) | Polipeptid s humanimi imunointerferonskimi (ifn-gama)lastnostmi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |